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The protein kinase DAI, the double-stranded RNA-activated inhibitor of translation, is an essential 
component of the interferon-induced cellular antiviral response. The enzyme is regulated by the binding of 
activator and inhibitor RNAs. We synthesized DAI in vitro and located its RNA-binding domain within the 
amino-terminal 171 residues. This domain contains two copies of an RNA-binding motif characterized by a 
high density of basic amino acids, by the presence of conserved residues, and by a probable ,,-helical structure. 
Deletion of either of the two motifs prevents the binding of dsRNA, but their relative positions can be 
exchanged, suggesting that they cooperate to interact with dsRNA. Clustered point mutations within the 
RNA-binding motifs and duplications of the individual motifs indicate that the first copy of the motif plays 
the more important role. Mutations that impair binding have similar effects on the binding of double-stranded 
RNAs of various lengths and of adenovirus VA RNA~, implying that discrimination between activator and 
inhibitory RNAs takes place subsequent to RNA binding. 
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Phosphorylation plays an important role in regulating 
the activities of many of the protein components of the 
translational machinery (Hershey 1989, 1990, 1991 ). One 
of the most intensively studied of these regulatory 
events involves the phosphorylation of eukaryotic initi- 
ation factor 2 (eIF-2). This factor is comprised of three 
different subunits (or, B, and ~) of which both the a and J3 
subunits are phosphorylated (Hershey 1990, 1991). Al- 
though the physiological significance of eIF-213 phospho- 
rylation remains to be determined, it is well established 
that phosphorylation of the ot-subunit can lead to the 
rapid cessation of protein synthesis (Hershey 1990, 
1991). In one of the first steps of translational initiation, 
eIF-2 transports the initiator tRNA IMet-tRNA~) in a ter- 
nary complex with GTP to the 40S ribosomal subunit 
(for review, see Moldave 1985; Pain 1986; Hershey 1991). 
The a- and ~3-subunits of eIF-2 are also involved in trans- 
lational start site selection in yeast (Donahue t al. 1988; 
Cigan et al. 1989). Before the association of the 40S com- 
plex with the 60S subunit to form the 80S ribosomal 
complex, eIF-2 is released in a binary complex with GDP 
that must be replaced by GTP to permit the binding of a 
flesh molecule of Met-tRNAi and reentry of the factor 
into the initiation process (Moldave 1985; Pain 1986; 
Hershey 1991). This regeneration is catalyzed by the gua- 
nosine nucleotide exchange factor (GEF or eIF-2B) 
(Konieczny and Safer 1983; Panniers and Henshaw 1983). 
If the a-subunit of eIF-2 is phosphorylated at Ser sl, the 
1Corresponding author. 
exchange reaction is blocked by the formation of a non- 
dissociable complex between GEF and eIF-2. GDP 
(Proud 1986; Colthurst et al. 1987). Initiation ceases in 
the absence of free GEF, and because GEF is present in 
cells at a lower concentration than eIF-2 (Safer 1983), the 
recycling factor may be completely sequestered when 
only a fraction (20-50%) of the eIF-2et in the cell is phos- 
phorylated. 
Three known protein kinases are capable of phospho- 
rylating eIF-2a on Set sl and they mediate a variety of 
control processes. In yeast, GCN2 kinase causes a gene- 
specific translational derepression rather than a general 
shutdown of polypeptide synthesis (Dever et al. 1992). 
Under starvation conditions, this kinase is responsible 
for the translational induction of the transcriptional c- 
tivator GCN4 by phosphorylating eIF-2et, thereby allow- 
ing ribosomes to bypass the regulatory open reading 
frames in the 5' leader sequence of GCN4 mRNA (Hin- 
nebusch 1990; Dever et al. 1992). GCN2 kinase is prob- 
ably activated by the presence of uncharged tRNAs (Wek 
et al. 1990). The other two eIF-2et kinases are character- 
istic of higher eukaryotes (for review, see Ochoa 1983; 
Mathews et al. 1990; Hershey 1991). The heme con- 
trolled repressor (HCR or HRI) is found mainly in retic- 
ulocytes. It is activated by a number of stimuli, most 
notably by the absence of heme or Fe 2 +, and it serves to 
prevent globin synthesis in the absence of its prosthetic 
group, heine (Jackson 1991). The third kinase, the dou- 
ble-stranded RNA (dsRNA)activated inhibitor (DAI, also 
termed DsI, p68, and P1 kinase), is present in most cell 
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types. DAI plays an important role in the interferon-in- 
duced antiviral response, and it has also been associated 
with cellular differentiation {Petryshyn et al. 1984; Jud- 
ware and Petryshyn 1991), the inhibition of cell prolifer- 
ation (Chong et al. 1992), the heat shock response 
(Dubois et al. 1989; Edery et al. 1989), and possibly tran- 
scriptional activation (Zinn et al. 1988). 
The regulation of DAI is poorly understood. The en- 
zyme is usually present in cells at a low level and in an 
inactive state. Its cellular concentration is increased by 
interferon at the transcriptional level (Hovanessian 
1989; Samuel 1991), whereas its activity is regulated by 
both activator and inhibitor RNAs (Mathews and Shenk 
1991). Activation of DAI is accompanied by autophos- 
phorylation of the latent enzyme, an event that appar- 
ently unmasks the ability of the enzyme to phosphory- 
late eIF-2oL (Farrell et al. 1977; Levin and London 1978; 
Sen et al. 1978; Berry et al. 1985; Galabru and Hovanes- 
sian 1987; Kostura and Mathews 1989). Optimal activa- 
tion of DAI requires dsRNA that is perfectly duplexed 
and greater than -85 bp in length, but there is no RNA 
sequence dependence {Hunter et al. 1975; Minks et al. 
1979, 1980; Manche et al. 1992). At relatively high con- 
centrations, activation is inhibited by short dsRNAs 
(less than -30  bp), which are not capable of activating 
DM (Minks et al. 1979, 1980; Manche et al. 1992). Fur- 
thermore, small, highly structured, single-stranded 
RNAs such as adenovirus virus-associated (VA) RNAI, 
the EBERs of Epstein-Barr virus, and TAR RNA encoded 
by human immunodeficiency virus-1 (HIV-1) are special- 
ized effectors: They block DAI activation at relatively 
high concentrations but are incapable of activating the 
enzyme (for review, see Mathews and Shenk 1991). Par- 
adoxically, at similar high concentrations, long dsRNA 
also becomes inhibitory {Hunter et al. 1975; Farrell et al. 
1977; Lenz and Baglioni 1978). 
To understand the complex molecular interactions be- 
tween DAI and RNA effectors, we undertook a muta- 
tional analysis of the protein, examining the ability of a 
variety of deletion, truncation, and substitution mutants 
to interact with RNA. The RNA-binding domain com- 
prises two basic regions located in the first 171 amino 
acids of the DAI sequence. Each of these regions contains 
a consensus RNA-binding motif and a putative a-helix. 
Mutations in the second motif are not as debilitating as 
similar mutations in motif 1, and the duplication of the 
second motif does not compensate for deletion of the 
first motif. Positional interchange of the two regions is 
not deleterious and their spacing can be varied, within 
limits, indicating that they cooperate to form the RNA- 
binding site. Clustered point mutations in these two re- 
gions affect the binding of long and short dsRNAs and of 
adenovirus VA RNA~ in the same way, implying that 
inhibitory RNAs bind to the same site as activators. 
Results 
Localization of the RNA-binding domain 
DM is a protein kinase that binds to dsRNA, leading to 
autophosphorylation a d activation of the enzyme's 
ability to phosphorylate eIF-2. Inspection of its predicted 
amino acid sequence, derived from a cDNA clone (Meurs 
et al. 1990; Thomis et al. 1992), suggested that the pro- 
tein can be divided into two regions of roughly equal 
size. The 270 amino acids of the carboxyl terminus con- 
tain the 11 subdomains that are essential for kinase ac- 
tivity and evidently comprise the catalytic domain of a 
protein kinase (Fig. 1A; Hanks et al. 1988). Because the 
first 280 amino acids of the protein are free of such cat- 
alytic domains, we hypothesized that this region is in- 
volved in regulating kinase activity and contains the 
RNA-binding domain{s) of the enzyme. The amino-ter- 
minal half of the protein possesses no RNA-binding mo- 
tifs typical of small nuclear ribonucleoproteins (s RNPs) 
(Kenan et al. 1989), but it contains a high density of 
lysine and arginine residues (Fig. 1B), which have been 
implicated in both DNA helix and RNA hairpin binding 
(Lazinski et al. 1989; Steitz 1990). These basic residues 
are concentrated in three distinct regions within the 
amino terminus of DM (Fig. 1A). To examine their role 
in RNA binding, we excised the basic regions individu- 
ally and assessed the ability of the deleted proteins to 
interact with RNA ligands. 
Templates encoding the three deletion mutants, A1, 
A2, and A3 (Fig. 1A), were transcribed in vitro with bac- 
teriophage T7 RNA polymerase, and the resultant RNAs 
were translated in a wheat germ cell-free system to gen- 
erate 3SS-labeled mutant proteins. These proteins were 
then compared to the full-length protein for their ability 
to bind to either dsRNA or adenovirus VA RNA~ coupled 
to Sepharose beads. Equal volumes of the translation 
products {Fig. 2A) were exposed to the immobilized 
ligands, and the resultant complexes containing radiola- 
beled protein were analyzed by gel electrophoresis and 
autoradiography (Fig. 2B,C). Neither a l  nor A2 {deletions 
of amino acids 1-97 and 104-157, respectively) was able 
to bind to dsRNA or VA RNA, but a3 (a deletion of 
amino acids 234-272) retained its ability to bind both 
types of RNA (Fig. 2B, C; lanes 3-5). Furthermore, a de- 
letion mutant lacking sequences near the carboxyl ter- 
minus (A4, a deletion of residues 482-523) and a point 
mutant in kinase domain II (Lys 296 ~ Arg) also bound 
to both RNA matrices (Fig. 2B, C; lanes 6 and 2). Back- 
ground binding to beads lacking an RNA ligand was neg- 
ligible (Fig. 2B, lane 8). These data suggested that the first 
two regions of basic amino acids are ssential for RNA 
binding, whereas the third basic region is not required. 
To vary the spacing between the first two basic re- 
gions, we also made two internal deletion mutants, A5 
and h6. Decreasing the distance between basic regions 1 
and 2 by four amino acids (AS) had very little effect on 
dsRNA binding, whereas removing 19 amino acids from 
this area (A6) abrogated sRNA-binding ability (see Fig. 
5, lanes 6,7 below). Therefore, the spacing is not abso- 
lutely critical, but some of the residues between the two 
basic regions appear to be indispensable. 
In addition to the full-length wild-type protein, many 
shorter polypeptides also bound to the dsRNA-Sepha- 
rose matrix (Fig. 2B, lane 1). The smallest of these poly- 
peptides, which are probably carboxy-terminal trunca- 
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Figure 1. Structure of DAd and mutants. (A) Schematic representation f full-length DAd and mutants. The top line represents he 
linear DAI protein sequence indicating the highly conserved kinase domains in the carboxy-terminal half of the protein (boxes I-XI) 
and the three basic regions within its amino-terminal half (thick lines 1, 2, and 3). The position of the single amino acid substitution 
in mutant K296R is marked. The lower lines depict the deletion mutants (Al-~6) and the sites of truncation (A7-M0). The numbers 
below each line denote the amino acid residues present in the deleted proteins. (B)LS mutants. The first 186 amino acids of the DAd 
sequence are represented, with the location of basic regions 1 and 2 indicated by hickening of the line. All the basic amino acids are 
boxed, and the residues changed by site-directed mutagenesis are shown with the mutant residues positioned above the mutated 
wild-type residues. Restriction enzyme sites used for the generation of truncated DNA (A7-A9) are also shown. 
tions resulting from premature termination events, had 
apparent molecular weights of <25,000. To define the 
minimum length of the amino-terminal segment of DAI 
required for RNA binding more precisely, truncated pro- 
teins were prepared (A7-A10, Fig. 1A) and tested in a 
similar manner. The truncated protein A9 (amino acids 
1-184) bound to both types of RNA affinity matrix (Fig. 
3A, lanes 6,9), whereas A7 (residues 1-155) did not bind 
efficiently {lanes 5,8), indicating that the carboxy-termi- 
nal boundary of the RNA-binding domain lies between 
residues 157 and 184. This assignment was confirmed in 
a second type of binding assay. DAI was immobilized on 
protein A-Sepharose beads by polyclonal antibody and 
was then exposed to synthetic 32p-labeled sRNA of 85 
bp. The bound RNA was quantitated by direct radioac- 
tive counting and visualized by electrophoresis and au- 
toradiography. Figure 3B shows that full-length DAI and 
the a9 truncated protein (residues 1-184) bound the la- 
beled dsRNA with similar efficiencies. Further experi- 
ments demonstrated that a reduction in length to 171 
amino acids (A8) had little or no effect on the ability of 
DAI to bind dsRNA, whereas truncation at residue 157 
(A7) effectively eliminated binding as in the dsRNA- 
Sepharose binding assay (see Fig. 5, lanes 2,3, below). 
Thus, we conclude that the KNA-binding domain lies 
within the first 171 amino acids of DAI, in agreement 
with the results of Katze et al. (1991) and Patel and Sen 
(1992). This domain contains both of the basic regions 
that appear to be essential. 
Mutational analysis of the RNA-binding domain 
To examine the two regions more closely, we made a 
series of clustered point mutations that changed basic 
amino acids to residues with uncharged side chains (Fig. 
1B; Table 1). The mutations were made in such a way 
that three adjacent amino acids were exchanged in each 
mutant by linker scanning mutagenesis. Initially, seven 
such mutants were generated, LS2-LS8, distributed 
through the two basic regions in A9 (residues 1-184). In 
addition, we constructed a number of double mutants by 
combining two LS mutations (e.g., LS3,5, which contains 
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Figure 3. RNA-binding activity of truncated DAI. (A) RNA- 
Sepharose assay. RNA from full-length wild-type construct and 
the truncations A7 and A9 was translated. Equal volumes of the 
translation products (5 ~1) were tested in both dsRNA-Sepha- 
rose and VA RNA-Sepharose-binding assays. Translation prod- 
ucts and adsorbed proteins were analyzed by electophoresis in 
15% polyacrylamide-SDS gels and autoradiography. (B) Immo- 
bilized DM assay. Equal amounts of radioactive protein of wild- 
type full-length and A9 DM were adsorbed to polyclonal anti- 
body and immobilized on protein A-Sepharose. After incuba- 
tion with 32P-labeled dsRNA {85 bp), the beads were washed and 
the resultant RNA-protein complexes were analyzed as in A. 
Figure 2. DAI translation and location of the RNA-binding 
domain. (A) Total translation products. Capped RNA tran- 
scripts synthesized by T7 polymerase in vitro, were used to 
program the wheat germ cell-free translation system. The re- 
sultant ranslation products were analyzed by electrophoresis in 
12.5% polyacrylamide-SDS gels and autoradiography. Lanes 
1-6 contain products from the wild-type clone (SRG2AL) and 
the mutants K296R, A1, A2, a3, and A4, respectively. Lane 7 
contains ~4C-labeled molecular weight markers. (B) Binding to 
dsRNA-Sepharose. The translation products (5 ~1) were incu- 
bated with dsRNA-Sepharose beads. After washing, the ad- 
sorbed proteins were analyzed as in A (lanes 1-7). (Lane 8) Con- 
trol using A4 protein and beads lacking RNA ligand. (C) Binding 
to VA RNA-Sepharose. As in B, except hat the translation 
products were incubated with VA RNA-Sepharose beads in- 
stead of dsRNA-Sepharose. 
both the LS3 and LS5 mutations). The mutant proteins 
were labeled by in vitro transcription and translation and 
were subjected to binding analysis using the dsRNA- 
Sepharose assay. 
Essentially equal amounts of protein were used in each 
assay (Fig. 4A). Strikingly, the introduction of the LS4 
mutation resulted in a dramatic shift in gel mobility. 
DM migrates anomalously during electrophoresis in 
SDS gels, with an apparent molecular weight of 68,000 
compared with 62,000 predicted from the cDNA se- 
quence (Meurs et al. 1990). The wild-type 184 residue A9 
protein migrated with the expected mobil ity (equivalent 
to -20  kD), but the LS4 substitution reduced its appar- 
ent molecular mass by -4  kD. This effect was not ob- 
served with any of the other LS mutations, suggesting 
that LS4 may disturb a structurally important region of 
the DAI molecule. Two different algorithms (Chou and 
Fasman 1974; Gamier et al. 1978) predict that the orig- 
inal LS4 residues represent the amino terminus of an 
a-helix lying between residues 58 and 82 in region 1 (see 
below and Fig. 8B). Although the LS4 mutation, like all 
of the mutations described here, had been verified by 
DNA sequence analysis, we confirmed that the aberrant 
mobil ity was not the result of the presence of an unde- 
Table 1. LS mutants  
Original Mutated 
Mutant Position residues residues 
LS2 18-20 Arg Gin Lys Gly Ala Leu 
LS3 38-40 Asp Arg Arg Gly Ala Leu 
LS4 58-60 Arg Set Lys Gly Ala Leu 
LS5 78-80 Glu Lys Lys Gly Ala Leu 
LS6 111-113 Lys Lys Arg Gly Ala Leu 
LS7 134-136 Lys Cys Lys Gly Ala Leu 
LS8 158-160 Ala Lys Leu Gly Ala Leu 
LS9 66-68 Ma Ala Ala Gly Ala Pro 
LS10 21-23 Glu Gly Val Gly Ala Leu 
LS 11 51-53 Glu Phe Pro Gly Ala Leu 
LS12 108-110 Ile Ala Gln Gly Ala Leu 
LS13 61-64 Lys Glu Ala Lys Ala Glu Ala Ma 
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Figure 4. Binding of dsRNA to DAI mutants using the dsRNA- 
Sepharose assay. (A)Total translation products. Uncapped RNA 
was synthesized from a number of mutant emplates truncated 
as for A9. Equal amounts of radioactive proteins were analyzed 
by electrophoresis in 20% polyacrylamide-SDS gels and auto- 
radiography. (B) Binding of DAI mutants to dsRNA. Equal 
amounts of labeled translated proteins were reacted with 
dsRNA-Sepharose beads ndanalyzed as in A. 
tected stop codon by truncating the template so as to 
yield a longer polypeptide of 278 residues (A10; Fig. 1A). 
Relative to the LS4 A9 polypeptide, the A 10 product ex- 
hibited the expected increase in apparent size (data not 
shown), thereby excluding the existence of undetected 
stop codons in the LS4 construct. However, this ex- 
tended LS4 protein still ran anomalously slowly in rela- 
tion to the wild-type A10 protein (data not shown), con- 
sistent with a structural peculiarity determined by the 
residues located in the region of the LS4 mutation. 
The ability of the mutant polypeptides tobind dsRNA 
varied dramatically (Fig. 4B). In the dsRNA-Sepharose 
assay, mutants LS3, LS5, and LS8 all appeared to bind 
dsRNA as efficiently as the wild-type A9 protein; LS6 
and LS7 bound at a reduced level; and LS2 and LS4 did 
not appear to bind at all. Thus, two of the single muta- 
tions in the first basic region (LS2 and LS4) completely 
abrogated sRNA binding, whereas two others (LS3 and 
LSS) had no effect. None of the single mutations in the 
second basic region (LS6, LS7 and LS8) had a dramatic 
effect on dsRNA binding, despite the observation that a 
deletion of this region eliminates RNA binding (Fig. 2A). 
However, when the mutations were combined to form 
double mutants, all nine of those tested displayed a sig- 
nificantly reduced ability to bind dsRNA (Fig. 4B). This 
was the case even with mutations in region 2 that had 
little effect on dsRNA binding individually (LS6, 7, LS6,8 
and LS7,8; Fig. 4B, lanes 14,15,17), suggesting that they 
act synergistically to impair dsRNA binding. 
To extend and quantitate these results, we turned to 
the alternative binding assay using immobilized DAI. 
This assay permits estimation of the dsRNA bound by 
direct radioactive counting {Fig. 5A), as well as visual- 
ization of dsRNA and DAI by autoradiography (Fig. 5B). 
The A9 truncated form of DAI (residues 1-184) and its 
mutant derivatives were labeled with [3ss-]methionine, 
bound to antibody-Sepharose b ads, and reacted with 
32p-labeled dsRNA. For the single mutants, LS2-LS8, the 
results agreed closely with those derived from the 
dsRNA-Sepharose-binding assay, although the immobi- 
lized DAI assay appeared to be more sensitive to small 
differences in binding efficiency. Thus, LS3, LS5, and 
LS8 bound 85, 60, and 116% as much dsRNA as wild 
type and LS6 and LS7 bound only -10-15% as much 
dsRNA as the wild-type polypeptide. Binding was insig- 
nificant in LS2 and LS4. Another mutant in the first 
basic region, LS13, which contains two Lys -o Ala sub- 
stitutions eparated by two unaltered residues {Fig. 1B; 
Table 1), also failed to bind detectable quantities of 
dsRNA (Fig. 5, lane 10). These data show that some, but 
not all, of the basic residues in the amino-terminus are 
critical for binding and confirm that both basic regions 
are important, although mutants in region 1 are more 
severely impaired. 
As expected from previous results {Fig. 4B), in general 
double mutants bound less dsRNA than the more se- 
verely impaired of the single mutants that constituted 
them (e.g., c.f. lane 12 with lanes 11 and 17). This was 
true even for those mutations (LS3, LSS, and LS8) that 
exerted minimal effects on their own, with one notable 
exception. Although the LS8 mutation caused a syner- 
gistic effect when combined with other region 2 muta- 
tions close to its own location (in LS6,8 and LS7,8), it 
exerted only a mart~inal effect when combined with 
more distant mutat~ns in region 1 {LS3,8 and LS5,8). 
This observation raises the possibility hat the two bind- 
ing regions function semiautonomously. 
Definition of an RNA-bmding motif 
Up to this point we have focused on the basic residues 
located in the amino-terminal third of the DAI molecule. 
Most mutations of such residues were deleterious to 
dsRNA binding, but it was not possible to decide on the 
basis of these experiments alone whether it was the 
charge change or the structural consequence of the mu- 
tation that was important. To address this question, we 
made further mutations altering nonbasic amino acids in 
the proximity of basic residues that are required for 
dsRNA binding. Mutants LS9-12 were constructed to 
alter residues near LS13, LS2, LS4, and LS6, respectively. 
The introduction of the LS10 mutation reduced the 
ability of DAI to bind dsRNA only slightly, despite the 
fact that alterations in the preceding 3 amino acids in 
LS2 destroyed all ability to bind dsRNA (Fig. 5, lanes 
8,33). On the other hand, the LS12 mutation reduced 
dsRNA-binding ability to 10% of the wild-type level, as 
seen for the adjacent mutation of basic residues, LS6 {Fig. 
5, lanes 21,35). The LS9 and LSll mutations impaired 
binding even more severely (Fig. 5, lane 32; see Fig. 7, 
lane 17, below). Therefore, changes in nonbasic residues 
within the amino terminus of DAI can also affect its 
dsRNA-binding ability, and the basic regions do not 
function simply as regions of positive charge. 
Consistent with this conclusion, inspection of the se- 
quence of this and other RNA-binding proteins sug- 
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Figure 5. Quantitation of dsRNA binding to DAI mutants using the immobilized DAI assay. 32p-Labeled dsRNA (85 bp) was adsorbed 
to 3SS-labeled proteins immobilized on antibody-Sepharose beads. (A) The amount ofbound dsRNA was determined by direct counting 
of radioactivity and is expressed relative to that adsorbed by the wild-type A9 protein. (B) RNA-protein complexes were analyzed by 
electrophoresis in 20% polyacrylamide-SDS gels and autoradiography. All mutant proteins were truncated s fora9, except for A8 and 
A7 (lanes 3,4). The controls inlanes 4 and 33 contained an unprogramed wheat germ extract and a mutant protein that is not recognized 
by the polyclonal antibody, respectively. 
gested the existence of a possible RNA-binding motif. 
Many of the deleterious mutations fall in highly con- 
served regions of the consensus equence (see Discus- 
sion). Because the motif is present once in each of the 
basic regions, it seemed possible that the duplication of 
one region would restore binding activity to a mutant 
from which the other region was deleted. To test this 
idea, we constructed mutants ub 1 : 1 and sub 2 : 2 con- 
taining tandem repeats of regions 1 and 2, respectively 
(Fig. 6B). The region 1 duplication bound dsRNA nearly 
as efficiently as wild-type DAd, whereas the region 2 du- 
plication was severely defective for dsRNA binding (Fig. 
6A), indicating that the two regions are not equivalent. 
Surprisingly, the mutant sub 2 : 1, in which the order of 
the two regions is reversed compared with the wild-type 
molecule, bound dsRNA with undiminished efficiency 
(Fig. 6). Similar data were obtained with VA RNA (not 
shown). These observations support he view that tan- 
dem copies of the motif are required for RNA binding but 
that motif 2 is less effective than motif 1. 
Binding of short RNA duplexes and VA RNA 
DM interacts with dsRNA in a length-dependent fash- 
ion: Duplexes of t--85 bp bind DAd and activate the en- 
zyme as efficiently as very long natural dsRNAs; short 
duplexes of ~<30 bp bind and activate the enzyme very 
weakly, and their most prominent effect is to inhibit 
activation by long dsRNAs; duplexes of intermediate 
size exhibit intermediate properties and also form elec- 
trophoretically distinct complexes with DAd (Manche et 
al. 1992). Such qualitative and quantitative differences 
might be reflected in differential effects of DM muta- 
tions on the binding of dsRNAs of varying sizes. For 
example, differential effects would be expected if short 
duplexes bound to a separate inhibitory site (Galabru et 
al. 1989). On the other hand, if there is a single site for 
binding both long and short dsRNA, residues at the ex- 
tremities of the dsRNA-binding site might be dispens- 
able for the binding of the smaller ligand. To determine 
whether DAd mutant proteins were capable of distin- 
guishing between dsRNAs of different sizes, a panel of 17 
mutants immobilized on antibody-Sepharose beads was 
challenged with 32P-labeled sRNA of 40 or 55 bp, as 
well as the 85-bp duplex used in previous experiments. 
The shorter dsRNAs bound less efficiently as expected 
(Manche et al. 1992), but the relative dsRNA binding 
was quantitatively unchanged among the DAd mutants 
(Fig. 7A). Thus, the relative binding efficiency of these 
mutants is independent of the length of the dsRNA, and 
DM mutations that discriminate between longer and 
shorter RNA duplexes were not identified. 
Adenovirus VA RNA~ is a small highly structured sin- 
gle-stranded RNA that binds to DAd and inhibits the 
binding of dsRNA (Kostura and Mathews 1989), as well 
as the activation of DAd by dsRNA (Kitajewski et al. 
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D iscuss ion  
DAI is a cellular protein kinase, subject o both positive 
and negative control by RNA effectors. Several functions 
have been attributed to DAI, the most studied of which 
is its role in the interferon-induced host antiviral re- 
sponse. Activation of the kinase by virus-derived sRNA 
shuts down protein synthesis and limits virus multipli- 
cation. As a counter-measure, some viruses synthesize 
short, highly structured single-stranded RNAs, such as 
VA RNA, which block the activation of DAI. To explore 
the molecular basis for these interactions we undertook 
a mutational analysis to define the RNA-binding do- 
main(s) in DAI. 
Two regions of DAI interact with RNA 
Noting that the amino terminus of the protein is rich in 
basic residues, we hypothesized that the positively 
charged side chains would form ionic bonds with the 
phosphodiester backbone of RNA. The basic amino acids 
are concentrated in three regions within the amino ter- 
minus of the protein. Deletion of the third basic region 
had no effect on RNA binding, but deletion of either the 
Figure 6. Interchange and duplication of RNA-binding motifs. 
{A) a2P-Labeled dsRNA was adsorbed to immobilized DAI mu- 
tant proteins. The amount of bound dsRNA is shown relative to 
that adsorbed by the wild-type DAI, truncated at amino acid 
residue 221. (B) Schematic representation f the proteins used in 
A. Numbers correspond to amino acid residues in the original 
DAI sequence. 
1986; O'Malley et al. 1986}. It is not clear whether this is 
the result of direct competition between VA RNA~ and 
dsRNA for a single binding site on DAI (Kostura and 
Mathews 1989} or whether there are separate binding 
sites for the activator and inhibitor {Galabru et al. 1989}. 
To address this question, we tested the same 17 DAI 
mutants for their ability to bind VA RNA~. The immo- 
bilized DAI assay gave a nonspecific background of VA 
RNA~ binding presumably owing to interaction with a 
wheat germ protein capable of binding VA RNA~; there- 
fore, we used the VA RNA-Sepharose assay for this 
study. The ability of the DAI mutants to bind to VA 
RNA I {Fig. 7B) matched the pattern obtained for dsRNA 
binding to immobilized DAI (Fig. 7AJ. As also seen with 
the truncation mutant A7 (Fig. 3A, lane 8), however, DAI 
mutants that are unable to bind dsRNA often interact o 
a small but detectable xtent with VA RNA-Sepharose. 
Because Sepharose beads lacking RNA ligands do not 
bind any detectable DAI {Fig. 2B, lane 8), this observation 
implies that DAI mutations that abrogate dsRNA bind- 
mg may still permit a weak interaction with VA RNAt. 
Further investigation of this phenomenon is under way. 
Figure 7. Binding of short dsRNAs and VA RNA. (A) Binding of 
dsRNA to immobilized DAI. RNAs of 40, 55, and 85 bp were 
exposed to mutant DAI proteins truncated as for Ag. RNA- 
protein complexes were analyzed by electrophoresis n 20% 
polyacrylamide-SDS gels and by autoradiography. The gels 
were exposed for 12,8, and 4 hr, respectively, to allow for the 
differing affinities of DAI for thethree RNAs. (B) Binding of DAI 
to VA RNA-Sepharose. Equal r dioactive counts of translated 
DAI mutant A9 proteins were incubated with VA RNA-Seph- 
arose beads. The resultant protein-RNA complexes were ana- 
lyzed by electrophoresis in 20% polyacrylamide-SDS gels and 
autoradiography. 
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first or second basic region rendered DAI unable to bind 
RNA. In agreement with recent results from other labo- 
ratories (Katze et al. 1991; Chong et al. 1992; Feng et al. 
1992; McCormack et al. 1992; Patel and Sen 1992), a 
truncated protein, comprising the first 171 amino acids 
and containing regions 1 and 2 in their entirety, was 
capable of binding RNA. Removal of an additional 14 
amino acids, encroaching on basic region 2, eliminated 
dsRNA binding, suggesting that some of these 14 resi- 
dues also contribute to the function of the molecule. We 
have demonstrated further that a bacterially produced 
protein consisting of residues 1-184 of DAI is able to 
give a gel mobility shift with dsRNA (Manche et al. 
1992), suggesting that post-translational modifications 
are not required for the RNA-binding activity of the pro- 
tein. 
Analysis of clustered point mutations in the first 184 
residues, and of molecules with duplications of the two 
basic regions, confirmed that both regions are required 
for RNA binding and suggested that they function coor- 
dinately by binding to different parts of the RNA mole- 
cule. Two observations support his view. First, although 
double mutants were generally more severely affected 
than either of the parental single mutants, they were 
always more debilitating if the two mutations were in 
the same region than if one mutation was in region 1 and 
the other was in region 2. This implies that the two 
regions function as partially independent units. Second, 
the observation that the positions of the two basic re- 
gions can be interchanged without loss of activity im- 
plies that they cooperate to give stable binding, presum- 
ably by interacting with different parts of the RNA mol- 
ecule. Yet the two regions are nonequivalent: Point 
mutations in region 1 were more debilitating than mu- 
tations in region 2, and a tandem repeat of region 1 was 
active while that of region 2 was not. Similarly, Feng et 
al. {1992} recently reported that deletions in region 1 are 
more deleterious than deletions in region 2. In the ab- 
sence of region 2, a TrpE-DAI fusion protein containing 
only the amino-terminal 98 residues of DAI, was able to 
bind RNA {McCormack et al. 1992). We and others [Patel 
and Sen 1992)find that region 1 fails to bind in the ab- 
sence of the TrpE sequences, suggesting hatthe bacte- 
rial protein can supply the region 2 function at least un- 
der some circumstances. 
RNA-binding motif and helix 
Their initial designation as basic regions notwithstand- 
ing, binding was abrogated by the substitution of either 
basic or non-basic residues. Although current data do not 
distinguish unequivocally between changes affecting 
residues that interact directly with RNA and changes 
that impact on the higher order structure of the enzyme, 
these results imply that the binding between DAI and 
RNA is more complex than a simple ionic interaction 
between the positively charged amino acids and the neg- 
atively charged RNA. The shift in electrophoretic mo- 
bility caused by LS4 suggested that this mutation lies in 
a region of stable secondary structure, andcomputer pre- 
dictions suggested the existence of an R-helix with a dis- 
tinct basic face and several other potential hydrogen 
bond-forming residues [Fig. 8B). The LS4 mutation re- 
moves two basic residues and introduces a glycine resi- 
due, which may affect the stability of the helix [Chou 
and Fasman 19741. To examine the importance of this 
helical domain, we made two additional mutations. 
First, the original alanine residues at the site of the LS9 
mutation were not expected to play a role in direct in- 
teractions with RNA, so their substitution with two he- 
lix-breaking residues (Gly and Pro) would be expected to 
disrupt the helical structure without altering interactive 
residues. Second, in LS13 two lysine residues were 
changed to alanine, thereby preventing the original basic 
residues from making electrostatic contacts with RNA 
while having a minimal effect on the predicted protein 
structure [Chou and Fasman 1974). Both of these mutant 
proteins were defective for dsRNA binding, implying 
that the charge and the structure of this ~-helix are im- 
portant for the interaction. 
Region 2 also contains a predicted R-helix, located be- 
tween residues 148 and 160, that displays equence ho- 
mology with the helix in region 1 and with sequences in
a number of viral and cellular RNA-binding proteins. A 
potential RNA-binding motif was derived from this con- 
sensus sequence [McCormack et al. 1992) and has since 
been found in other known RNA-binding proteins uch 
as the TAR RNA-binding protein [TRBP [S. Venkatesan, 
pers. comm.)]. This core motif encompasses the cx-helix 
in region 1 that we have identified as essential for 
dsRNA binding, thereby establishing that the motif is an 
essential component of the DAI dsRNA-binding domain. 
Further scrutiny reveals that the motif can be extended 
upstream of the original consensus equence in that 
amino acids 11-77 and 101-167 of DAI display regions of 
homology throughout heir length with other RNA- 
binding proteins [Fig. 8A [D. St Johnston and S. Venkate- 
san, pers. comm.). Several considerations support the 
view that this extended homology is of significance. 
First, most of regions 1 and 2 are included in these 
stretches of extended homology, and in each case, the 
original core motif is located in the area of greatest ho- 
mology. Second, the extended motif incorporates resi- 
dues between 157 and 171, which are important for bind- 
ing, and there is no repeat of this motif in region 3, which 
is dispensable for RNA binding. Third, mutations in re- 
gion 1 that are essential for function [LS2, LS4, LS9, 
LS11, and LS13) lie in conserved amino acids, whereas 
mutations that have little effect on dsRNA binding [LS3, 
LS5, and LS10) are in regions of weak homology or non- 
conserved regions. In keeping with the lesser dependence 
on region 2, mutations in this region are less deleterious 
even though some region 2 mutations lie in similar po- 
sitions within the extended homology to those in basic 
region 1 (LS6, LS8, and LS12}. The most striking differ- 
ence is seen with LS8, which partially overlaps the LS9 
site, but the significance of this discrepancy is attentu- 
ated by the fact that the changes within the two consen- 
sus sequences are not identical. Finally, in TRBP, dele- 
tions of a region corresponding to one of the highly con- 
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Figure 8. RNA-binding motifs. {A) Consensus sequence for 
an extended RNA-binding motif. Amino acids 11-77 and 
101-167 of the human DAI sequence are compared with
other RNA-binding proteins (vaccinia virus E3L protein, ro- 
tavirus NS34 protein, TAR RNA-binding protein, and the 
mouse DAI homolog TIK). Similar or identical amino acids 
present at the same position in four or more of the sequences 
are shown in boldface type as lowercase oruppercase letters, 
respectively. [B) The amino terminus of the predicted a-helix 
in region 1. The first 7 amino acids of the a-helix are dia- 
gamed to demonstrate the potential for interactions be- 
tween the helix and RNA. {C) Bivalent binding to dsRNA. 
The model illustrates how the two RNA-binding motifs 
could interact with the dsRNA helix. Optimal binding oc- 
curs when the two motifs pan -80 bp (Manche et al. 19921. 
We speculate that binding to shorter duplexes entails in- 
creased strain at the "hinge" between the two motifs, 
thereby lowering binding efficiency, and that only monova- 
lent binding is possible with duplexes of 30 bpor less. 
Vaccin ia E3L 
Rotavirus NS34 
TRBP 1 
TRBP 2 
mDAI 1 
mDAI 2 
hDAI 1 
hDAI 2 
Consensus 
served motifs abrogate RNA binding, and a 24-residue 
peptide analogous to this motif is able to interact with 
RNA {A. Gatignol, pets. comm.J. 
The 18-residue core motif, which we have identified as 
essential for dsRNA binding, is located at the amino ter- 
minus of a predicted a-helix in all of the RNA-binding 
proteins considered here. In DNA-binding proteins, 
three well-characterized motifs, the zinc finger, the he- 
l ix-tum-helix, and the leucine zipper, all make protein- 
DNA interactions by inserting an c~-helix into the major 
groove of the DNA helix. In the case of the helix-turn- 
helix and zinc finger motifs, it is the amino terminus of 
the or-helix that makes these interactions. The dsRNA- 
binding proteins may make similar contacts, although 
the A-form configuration of dsRNA would require the 
a-helices to be inserted into the minor groove because 
the major groove is too narrow in this conformation 
(Steitz 1990}. An example of this kind of interaction oc- 
curs in the complex between glutaminyl tRNA synthe- 
tase and its uncharged cognate tRNA (Rould et al. 1989). 
Regulation of DAI 
Of the RNA-binding proteins discussed here, the viral 
proteins have one copy of the core motif, whereas the 
cellular proteins have two copies. When two motifs are 
present, they appear to be functionally nonequivalent: 
The first of the TRBP motifs is dispensable (A. Gatignol, 
pets. comm.) and the second motif in DAI plays an es- 
sential but subsidiary role. What, then, is the fianction of 
the second binding motif in DAI.~ One possibility is that 
region 2 is responsible for presenting the region 1 a-helix 
in the correct position or orientation for interaction with 
dsRNA. Ahematively, both regions may be involved in 
direct interactions with dsRNA, either acting in con- 
junction to create one binding site or binding to different 
areas of the dsRNA. 
Both hypotheses would fit with the results of the A5 
and A6 deletions, because a slight reduction in the spac- 
ing between the two essential regions might be tolerated, 
whereas a large deletion could prevent he two regions 
from functioning in unison. We strongly favor the sec- 
ond model because it ascribes similar functions to the 
homologous regions, consistent with the results ob- 
tained with tandem duplications and rearrangements, 
and provides a natural explanation for the differing affin- 
ities of DAI for dsRNAs of different sizes. Earlier work 
showed that as dsRNA chain length is increased, maxi- 
mal enzyme activation and RNA-binding efficiency are 
reached at 85 bp [Minks et al. 1979~ Manche et al. 1992}. 
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We propose that this length affords optimal spacing for 
the two RNA-binding motifs to interact with separate 
sites on the duplex (Fig. 8C). The shorter the dsRNA, the 
lower the probability that DAI will form the correct con- 
formation for this interaction and, therefore, the lower 
the efficiency of binding. This hypothesis could also ex- 
plain the discontinuous behavior of DAI-dsRNA com- 
plexes in gel mobility analyses (Manche et al. 1992). In 
these experiments, complexes were formed with 
dsRNAs of 40-65 bp; but when the chain length in- 
creased past a critical value ( -85 bp), the predominant 
complexes abruptly migrated considerably faster in na- 
tive gels. We assume that longer dsRNAs permit the for- 
mation of a more compact protein-RNA conformation 
with a resulting increase in gel mobility and that this 
conformational change allows for DAI activation. The 
stretch of polypeptide sequence between the two binding 
regions might act as a hinge that is set under progres- 
sively greater strain as the length of the duplex is re- 
duced from 85 to 30 bp, resulting in lower binding affin- 
ity (Fig. 8C). Below 30 bp, the range of the hinge's move- 
ment is exceeded and the protein can only interact with 
the duplex through a single motif, resulting in greatly 
reduced affinity and failure to detect complex formation. 
The regions of DAI that interact with dsRNA are also 
involved in VA RNAr binding. Within these regions, 
amino acid substitutions have very similar effects on the 
binding of both dsRNA and VA RNAI implying that both 
copies of the RNA-binding motif and the same amino 
acids are required for VA RNA~ binding. VA RNAt is 
comprised of two duplex regions, the apical and terminal 
stems, separated by a region of more open structure, 
termed the central domain (Mellits and Mathews 1988; 
Furtado et al. 1989), but it does not contain long 
stretches of continuous duplex. DAI binds to the apical 
stem (Mellits et al. 1990a) and the central domain 
(Ghadge t al. 1991; P. Clarke, unpubl.), perhaps because 
one motif binds to the apical stem and the other to the 
central domain. Why, then, is VA RNA an inhibitor? 
One strong possibility is that although VA RNAI binds 
to both motifs, the structure of the resultant RNA-pro- 
tein complex is incompatible with the conformational 
change that permits the autophosphorylation a d acti- 
vation of DAI. 
In conclusion, we have shown that two copies of an 
extended RNA-binding motif are essential for RNA bind- 
ing by DAI. The motif is rich in basic residues and con- 
tains a potential a-helical structure. We propose that 
both motifs interact with RNA by inserting the a-helical 
domain into the minor groove of the RNA double helix 
and causing a conformational change in the enzyme that 
is required for its activation. It remains to be seen 
whether similar RNA-protein interactions participate in 
the functioning of other proteins that share this motif. 
Mater ia ls  and methods  
Vectors 
Plasmid p84a (Meurs et al. 1990; provided by B. Williams, 
Cleveland Clinic Foundation, Cleveland, OH) contains the 
cDNA encoding DAI inserted between the XbaI and HindIII 
sites of the vector Bluescript KS. A derivative, p84b, was gen- 
erated by joining the PstI site in the 3'-untranslated region of 
the cDNA to the SalI site in the vector with a BamHI linker 
(CGGATCCG). Plasmid pPK1, (a gift of J. Field, Cold Spring 
Harbor Laboratory) contains the T7 RNA polymerase promoter 
driving the synthesis of an influenza virus HA1 epitope fused to 
the amino terminus of cyclic AMP-dependent protein kinase. 
To create avector expressing an HA1-DAI fusion protein, pPK1 
was digested with SalI and p84b was digested with HindIII (at 
nucleotide -30 in the 5'-untranslated region of the DAI se- 
quence). The resultant 3'-recessed ends were blunted and both 
DNAs were digested further with BamHI. After gel purification, 
the 1.8-kb fragment containing the entire DAI-coding region 
was ligated into the pPK1 background (in place of the cAMP- 
dependent protein kinase sequencesl to produce pSRG2. Subse- 
quently, to remove the HA1 leader sequences, pSRG2 was 
cleaved with NdeI (at the start of the HA1 sequence) and Hin- 
dIII, both recessed ends were blunted, and the DNA was reli- 
gated. The resultant plasmid, pSRG2AL, contains the 5'-un- 
translated sequence of DAI immediately downstream from the 
T7 promoter. Proteins derived from this vector initiate at the 
natural DAI start codon. 
Construction of DAI mutants 
Most constructs were prepared in plasmid pUC118D, contain- 
ing the HindlII-BamHI DAI fragment from p84b inserted be- 
tween equivalent sites in pUC118. Mter mutagenesis, the rel- 
evant fragments were excised from pUC 118D by digestion with 
HindlII and MscI and inserted into a comparably cut pSRG2AL 
background. Three types of mutant were produced: Deletions 
and rearrangements of large blocks of sequence were made using 
conveniently located restriction enzyme sites, whereas mall 
deletions and substitutions were made by site-directed mu- 
tagenesis. The mutants are diagramed in Figure 1 and were all 
confirmed by DNA sequencing. 
Deletion A1 was prepared by digesting SRG2 with NdeI and 
NcoI. Both 3'-recessed ends were filled, and the plasmid re- 
closed by self ligation. A2 was constructed by digesting 
pUC118D with Fnu4HI and filling in the 3'-recessed end. The 
DNA was digested further with BamHI, and the resultant 1320- 
bp fragment was ligated into pUC118D digested with StuI and 
BamHI. A3 was constructed by digesting pUCll8D with 
BsmAI. The 5' extension was removed by treatment with mung 
bean nuclease (New England Biolabs), before further digestion 
with HindlII to liberate a 723-bp fragment. A second fragment 
was prepared by digesting pUC118D with AseI and filling in the 
3'-recessed end. This linearized plasmid was digested further 
with EcoRI to produce a 283-bp fragment. These two fragments 
were then ligated into pUC 118 digested with HindlII and EcoRI 
in a triple fragment ligation. To construct A4, pUC118C was 
made by digesting pUC118D with HindlII and AccI. The ends 
were blunted and religated so that only the carboxyl terminus of 
DAI remained, pUC 118C was then digested further with XmnI 
and Saul., again, the ends were blunted and the vector was reli- 
gated. The deletion was transferred into an SRG2AL background 
by exchanging MscI-BamHI fragments. 
Three mutants contain rearrangements of the amino termi- 
nus of DAI. Sub 2:1, in which two blocks of sequence are 
inverted, was produced by inserting DNA encoding amino acids 
1-103 at the BsaAI site of hl. The same fragment was inserted 
between the StuI and BsaAI sites of SRG2AL to create sub 1 : 1, 
which contains aduplication of region 1 and a deletion of region 
2. Sub 2 : 2, which has a duplication of region 2 and a deletion 
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of region 1, was produced by inserting a StuI-BsaAI fragment 
from SRG2AL into the BsaAI site of A1. 
The two smaller deletions, A5 and a6, and the linker scanning 
(LS) mutants were constructed in pUC118D, using the oligonu- 
cleotide-directed mutagenesis technique (Kunkel 1985), and 
were subsequently transferred into the SRG2AL background. 
With two exceptions, the oligonuceotide primers used to con- 
struct he LS mutants contained the central sequence GGGGC- 
CCT, which converted the target amino acid sequence to Gly- 
Ala-Leu. In LS9, the central sequence of the mutagenic oligo- 
nucleotide was GGGGCCCC, modifying the amino acid 
sequence to Gly-Ala-Pro. In LS13, Lys 61 and Lys 64 were  both 
changed to Ala by mutating their codons to GCA. The amino 
acid changes are summarized in Table 1. Oligonucleotide-di- 
rected mutagenesis was also carried out to substitute Arg for 
Lys 296, the residue essential for the proton transfer activity in- 
volved with kinase function. After converting the AAA triplet 
to AGA, the mutation was transferred from pUC118C into an 
SRG2 background to produce K296R. 
Production of polyclonal antibody against DAI 
The Escherichia coli strain BL21(DE3) (Studier and Moffatt 
1986) was transformed with plasmid pSRG2, and induction of 
DAI was carried out as described (Sambrook et al. 1989). Al- 
though trace amounts of DAI were detected by Western blot 
analysis, the cells died before significant amounts of protein had 
accumulated. However, large quantities of protein were pro- 
duced by cells expressing the mutant protein K296R, which is 
nonfunctional for kinase activity (Katze et al. 1991). This pro- 
rein, which was visible by Coomassie brilliant blue R staining 
of polyacrylamide gels containing crude cell extracts of such 
cells, was found in both the supernatant fraction and inclusion 
bodies. To purify the mutant DAI, a culture grown at 25~ was 
lysed and inclusion bodies were prepared as described previ- 
ously {Marston 1987). The washed inclusion bodies were soni- 
cated in modified buffer B {Kostura nd Mathews 1989) contain- 
ing 20 mM potassium phosphate [pH 6.8) (instead of HEPES) and 
8 M urea to solubilize the DAI. This suspension was then passed 
over an S-Sepharose {Pharmacia) column, and the bound DAI 
was eluted with 150 mM KC1. Peak fractions were pooled and 
dialyzed overnight against 100 volumes of modified buffer B 
containing 20 mM Tris-HC1 (pH 9.0) (instead of HEPES) and 8 M 
urea. The dialysate was loaded onto a Q-Sepharose (Pharmacia) 
column, and again the bound DAI was eluted with 150 mM KC1. 
DAI-containing samples were fractionated by electrophoresis 
through 12.5% polyacrylamide-SDS gels, and the band corre- 
sponding to DAI was excised. The gel fragment was prepared for 
immunization and injected into rabbits as described (Harlow 
and Lane 1988). A high level of antibody was detected after three 
injections. 
Synthesis of DAI proteins 
A wheat germ translation extract was prepared as described 
(Roberts and Paterson 1973). Translation reactions were carried 
out in a final volume of 25 ~1, containing 7.5 ~1 of lysate, 160 
p, Ci/ml of [aSS]methionine (ICN Biomedicals), 24 mM HEPES 
(pH 7.4), 25 mM potassium acetate, 2 mM DTT, 1 mM ATP, 25 
~M GTP, 8 mM creatine phosphate, 250 ~M spermidine, 25 ~M 
amounts of each amino acid except methionine, and 12.5 ~g/ml 
of calf liver tRNA. Reactions were programed with 0.5 ~g of 
RNA and incubated at 20-25~ for 2 hr. From each translation 
reaction, 2 ~l was spotted onto Whatman 3MM paper, and pro- 
teins were precipitated by boiling in 10% (vol/vol) TCA for 5 
min. The relative amounts of radioactive protein synthesized 
were determined by liquid scintillation. 
Uncapped RNA was generated as described (Mellits et al. 
1990b) and used as a template for synthesis of truncated DAI. 
Capped RNA was used for the synthesis of full-length DAI: It 
was generated in transcription reactions containing 0.2 mM 
GTP and 0.5 mM mTGpppG. All RNA was purified by extraction 
with phenol and with chloroform/isoamyl alcohol (24 : 1). The 
RNA was precipitated with ethanol, dissolved in TE {10 mM 
Tris-HC1 at pH 7.4, 1 mM EDTA) and passed twice through 
Sephadex G-50 medium (Pharmacia) spin columns {Sambrook 
et al. 1989). The eluted RNA was precipitated with ethanol and 
dissolved in TE. 
Binding of DAI to RNA-Sepharose matrices 
Two kinds of RNA matrix were prepared, dsRNA-Sepharose 
and VA RNA-Sepharose. Penicillium chrysogenum dsRNA was 
a gift from H. Robertson (Comell University Medical College, 
NY). VA RNA I was generated by transcription with T7 RNA 
polymerase as described (Mellits et al. 1990b) and purified by 
electrophoresis through a native polyacrylamide gel. In both 
cases, the RNA ligand was linked to CNBr-activated Sepharose 
(Pharrnacia) as described (Kadonaga nd Tjian 1986}. DAI-bind- 
ing reactions contained equal amounts of aSS-labeled wild-type 
and mutant proteins (5-10 ~1 of translation products) and were 
conducted with 50 ~1 of RNA matrix by the method of O'Malley 
et al. (1986), with the exception that binding to VA RNA-Seph- 
arose was carried out on ice. 
Binding of RNA to DAI-Sepharose matrix 
Equal amounts of DAI protein (-50,000 cpm; 5-10 ~1 of trans- 
lation products) were adsorbed to protein A-Sepharose b ads 
saturated with 5 ~1 of polyclonal antibody. Radiolabeled 
dsRNAs (Manche et al. 1992) and VA RNAI (Mellits et al. 1990b) 
were generated in vitro. RNA binding was carried out as de- 
scribed previously (Mellits et al. 1990a) using final concentra- 
tions of 50 ng of dsRNA/ml and 100 ng of VA RNA~/ml. Under 
the same conditions, single-stranded RNA of 85 nucleotides 
(Manche et al. 1992) gave only weak and nonspecific binding. 
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